Prestige Biologics

THE PRESTIGE BIOPHARMA GROUP SUPPORT THE EXPEDITED QUALITY DEVELOPMENT AND COMMERCIALIZATION OF EXISTING AND FUTURE BIOLOGICS AND VACCINES IN A FULLY COORDINATED APPROACH. TOGETHER THEY HAVE ENABLED THE GROUP TO BECOME ONE OF THE MOST COMPETITIVE PLAYERS IN THE GLOBAL BIOPHARMACEUTICAL INDUSTRY.

PRESTIGE BIOPHARMA LIMITED PIONEERS BIOTHERAPEUTIC AND VACCINE DEVELOPMENT RESEARCH WITH THE AIM OF FINDING CURES AND PREVENTATIVE MEDICINES FOR DEVASTATING DISEASES, AND TO PROVIDE THE ESSENTIAL ACCESS TO AFFORDABLE
QUALITY BIOLOGICS TO THE PATIENTS OF THE WORLD.

PRESTIGE BIOLOGICS CO., LTD IS THE GROUP’S DEDICATED CDMO THAT PROVIDES EFFICIENT AND HIGH-QUALITY COMPLETE SOLUTIONS TO DEVELOPMENT AND MANUFACTURING REQUIREMENTS THROUGHOUT DRUG DEVELOPMENT CONTINUUM
FROM THE EARLY-STAGE CONCEPT OF CLINICAL BIOPHARMACEUTICALS THROUGH TO FULL, GLOBAL COMMERCIALIZATION OF PRODUCTS.

https://www.prestigebio.com/